Mechanical properties as printability predictors of Paroxetine-loaded filaments by fused deposition modeling

Poster presented at the 80th FIP World Congress of Pharmacy and Pharmaceutical Sciences. Seville, Spain, 18-22 September 2022N/

3+4 Affiliation Agreement for a Combined Bachelor of Science and Doctor of Pharmacy (PharmD)

Affiliation agreement between SUNY, University at Buffalo, School of Pharmacy and Pharmaceutical Sciences (SPPS) and the College at Brockport, SUN

Challenges to medical device accessibility following the New European Union regulations governing notified bodies for medical devices

The EU medical device (MD) regulatory structure has changed from Directives to Regulations to ascertain safety, quality, and efficacy of MDs in the EU market. The EU Regulations are complex and have increased safety partly by adapting stringent requirements for Notified Bodies (NBs).peer-reviewe

A comparative analysis of professional background and experience for the responsible person position in pharmaceutical wholesale distribution

According to the ‘Guideline on Good Distribution Practice of Medicinal Products for Human Use’ (European Directive 2001/83/EC), the role of the Responsible Person (RP) is vital to uphold principles of Good Distribution Practice (GDP) requirements. This guideline requires a technical person, the RP, who is responsible for the overall implementation of GDP. GDP guidelines globally define the legally binding responsibilities to ensure that medicinal products maintain safety, quality and efficacy in wholesale distribution. Structured educational programmes for the accession to the RP position are not established globally for personnel working in the pharmaceutical wholesale distribution setting.peer-reviewe

Entrepreneurship in pharmaceutical processes

The current environment in healthcare is affected by several factors including issues related to rising costs and affordability, challenges of chronic diseases, evolvement of the workforce, benefits and challenges of regulatory sciences and situations such as crisis management in a pandemic or conflict. Pharmacists are presented with the challenge of undertaking innovative practices to transform the healthcare system and create novel opportunities and revenue streams. Innovation and entrepreneurship are critical aspects which support economic growth and development. The application of entrepreneurship to pharmaceutical processes may enable the achievement of improvements in healthcare.peer-reviewe

Medicinal cannabis use in rare diseases

Rare diseases (RDs) affect over 300 million people worldwide. There are approximately 7,000 recognised RDs. RDs are usually genetic and are associated with severe debilitating symptoms which persist for a patient’s lifetime. RD patients face multiple challenges including delay in accurate diagnosis and significant unmet need for beneficial therapies. For 90 % of RDs there are no effective therapies. Medicinal Cannabis (MC) is used to relieve symptoms, such as pain, muscle spasticity and anxiety, which may be commonly experienced by patients with RDs. Being able to manage the symptoms and the progression of diseases, can positively impact patients, families and health care systems.peer-reviewe

Reflections on the use of cannabidiol for medicinal purposes and the views of healthcare professionals

The cannabis plant has more than one hundred cannabinoids. The two most researched cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). Demand for CBD products grew with healthcare professionals recommending CBD for potential therapeutic effects.peer-reviewe

Developing a framework for pharmacist prescribing : a risk-based approach

Non-medical prescribing allows for streamlined access to medication, leading to a reduced workload for general practitioners and increased professional satisfaction for pharmacists. Determining patient’s perception of the risks involved with an expanded prescribing model is important before implementation, to determine acceptability of the prescribing model.peer-reviewe

Knowledge and application of green practices within community pharmacy

The leaching of active pharmaceutical ingredients within the environment can be reduced if greener practices are adopted throughout the lifecycle of pharmaceutical products. Being at the forefront of healthcare systems, pharmacists and the pharmaceutical workforce have an important role in reducing the impact of pharmaceutical related activities.peer-reviewe

Pharmaceutical regulation, policy and access to medicines in the European Union

European health systems have traditionally aimed at the provision of high-quality care and equity of access. This has become increasingly challenging over the past decades, with unabated pressure to deliver more and better services with insufficient resources . In the pharmaceutical arena, there is growing concern and interest in the area of access to medicines in the European Union. Whilst member states are bound by a legislative infrastructure which addresses quality, safety and efficacy of medicinal products on the market, patients in these territories experience disparate levels of access to medicines . Paradigms for improvements in this field most often focus on the individual barrier and do not relate to the wider perspective.peer-reviewe